Research graph
References from Temporal and clinical heterogeneity of double M-protein multiple myeloma: diagnostic and treatment-emergent phenotypes. Local targets link to admitted publications; unresolved targets remain external evidence.
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
10.1016/s1470-2045(14)70442-5 · 2014 · External reference
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
10.1016/s1470-2045(16)30206-6 · 2016 · External reference
Clinical characteristics and outcomes in biclonal gammopathies
10.1002/ajh.24319 · 2016 · External reference
Molecular analysis of immunoglobulin genes reveals frequent clonal relatedness in double monoclonal gammopathies
10.1038/bcj.2013.12 · 2013 · External reference
Monoclonal gammopathy with double M-bands: an atypical presentation on serum protein electrophoresis simulating biclonal gammopathy
10.4103/ijpm.ijpm_311_17 · 2017 · External reference
Evaluation of double M-band on serum protein electrophoresis simulating biclonal gammopathy: a case report
10.1007/s12291-020-00929-y · 2022 · External reference
Single monoclonal spike characterized as double monoclonal gammopathy in a patient with multiple myeloma: a rare finding
10.4103/ijpm.ijpm_904_21 · 2024 · External reference
Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference
10.1515/cclm-2021-0399 · 2021 · External reference
Mass spectrometry profiling of therapeutic antibodies in multiple myeloma: m/z features and concordance with immunofixation electrophoresis
10.3390/biomedicines13122933 · 2025 · External reference
A personalized mass spectrometry-based assay to monitor M-protein in patients with multiple myeloma (EasyM)
10.1158/1078-0432.ccr-21-0649 · 2021 · External reference
Peripheral measurable residual disease activity assessment by MALDI-TOF mass spectrometry in patients with newly diagnosed multiple myeloma in the phase III GMMG-HD7 trial
10.1200/jco-26-01346 · 2026 · External reference
Evaluation of assumed tumour volume in multiple myeloma using dual-energy spectral CT and its correlation between haematological findings
10.1016/j.ejro.2025.100675 · 2025 · External reference
Association of ANA and SSA autoantibodies with progression-free survival in multiple myeloma: a retrospective cohort study
10.3389/fonc.2025.1529678 · 2025 · External reference
Clinical characteristics and outcomes in biclonal gammopathies
10.1002/ajh.24319 · ExternalCitation · doi-reference
Evaluation of double M-band on serum protein electrophoresis simulating biclonal gammopathy: a case report
10.1007/s12291-020-00929-y · ExternalCitation · doi-reference
Evaluation of assumed tumour volume in multiple myeloma using dual-energy spectral CT and its correlation between haematological findings
10.1016/j.ejro.2025.100675 · ExternalCitation · doi-reference
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
10.1016/s1470-2045(14)70442-5 · ExternalCitation · doi-reference
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma
10.1016/s1470-2045(16)30206-6 · ExternalCitation · doi-reference
Molecular analysis of immunoglobulin genes reveals frequent clonal relatedness in double monoclonal gammopathies
10.1038/bcj.2013.12 · ExternalCitation · doi-reference
A personalized mass spectrometry-based assay to monitor M-protein in patients with multiple myeloma (EasyM)
10.1158/1078-0432.ccr-21-0649 · ExternalCitation · doi-reference
Peripheral measurable residual disease activity assessment by MALDI-TOF mass spectrometry in patients with newly diagnosed multiple myeloma in the phase III GMMG-HD7 trial
10.1200/jco-26-01346 · ExternalCitation · doi-reference
Monitoring the M-protein of multiple myeloma patients treated with a combination of monoclonal antibodies: the laboratory solution to eliminate interference
10.1515/cclm-2021-0399 · ExternalCitation · doi-reference
Association of ANA and SSA autoantibodies with progression-free survival in multiple myeloma: a retrospective cohort study
10.3389/fonc.2025.1529678 · ExternalCitation · doi-reference
Mass spectrometry profiling of therapeutic antibodies in multiple myeloma: m/z features and concordance with immunofixation electrophoresis
10.3390/biomedicines13122933 · ExternalCitation · doi-reference
Monoclonal gammopathy with double M-bands: an atypical presentation on serum protein electrophoresis simulating biclonal gammopathy
10.4103/ijpm.ijpm_311_17 · ExternalCitation · doi-reference
Single monoclonal spike characterized as double monoclonal gammopathy in a patient with multiple myeloma: a rare finding
10.4103/ijpm.ijpm_904_21 · ExternalCitation · doi-reference
